Abstract

Breast cancer is the most common malignancy and cause of cancer-related mortality among women worldwide. Triple negative breast cancers (TNBC) are the most aggressive and lethal of the breast cancer molecular subtypes, due in part to a poor understanding of TNBC etiology and lack of targeted therapeutics. Despite advances in the clinical management of TNBC, optimal treatment regimens remain elusive. Thus, identifying interventional approaches that suppress the initiation and progression of TNBC, while minimizing side effects, would be of great interest. Studies have documented an inverse relationship between the incidence of hormone receptor negative breast cancer and adherence to a Mediterranean Diet, particularly higher consumption of fish and olive oil. Here, we performed a review of studies over the last 5 years investigating the effects of fish oil, olive oil and their components in model systems of TNBC. We included studies that focused on the fish oil ω-3 essential fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in addition to olive oil polyphenolic compounds and oleic acid. Both beneficial and deleterious effects on TNBC model systems are reviewed and we highlight how multiple components of these Mediterranean Diet oils target signaling pathways known to be aberrant in TNBC including PI3K/Akt/mTOR, NF-κB/COX2 and Wnt/β-catenin.

Highlights

  • Breast cancer is the most common malignancy and cause of cancer-related mortality among women worldwide [1]

  • There have been advances in chemotherapeutic regimens for Triple negative breast cancer (TNBC) [2], there is a potential benefit to identifying lifestyle interventions that target molecular effectors of TNBC initiation and progression

  • The diet is a key example of a modifiable risk effector that influences a myriad of molecular processes with both positive and negative implications toward mammary tumorigenesis

Read more

Summary

Introduction

Breast cancer is the most common malignancy and cause of cancer-related mortality among women worldwide [1]. Triple negative breast cancer (TNBC) refers to a heterogeneous subclassification of breast tumors that by definition lack expression of the estrogen receptor (ER)α, progesterone receptor (PR) and human epidermal growth factor receptor (HER). Triple negative breast cancer (TNBC) refers to a heterogeneous subclassification of breast tumors that by definition lack expression of the estrogen receptor (ER)α, progesterone receptor (PR) and human epidermal growth factor receptor (HER)2 These tumors account for Mediterranean Diet and Breast Cancer. For TNBC, the 5y survival rate for stage I patients is ≥85% compared with ≥99 and ≥94% for luminal (A and B) and HER2+ breast cancer, respectively. In the metastatic setting, the median survival for TNBC is ∼10–13 mo compared to ∼5 y for non-TNBC

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call